- S&P 500 7,659.44 −1.09%
- Dow Jones 52,002.41 −0.34%
- Nasdaq 26,713.03 +0.08%
- VIX 19.99 +21.45%
- 10-year Treasury 5.09% −0.01
- Dollar index 121.40 −0.14%
- WTI crude $101.91 +1.04%
Health care
Drugmakers, biotech, medical devices, hospitals and insurers that run health plans. 1,348 listings in our snapshot of Oct 19, 2026, of which 1,217 U.S.-listed companies are worth $10.8T together. Prices and market values from public market data and SEC filings.
At a glance
Drugmakers, biotech, medical devices, hospitals and insurers that run health plans. Returns are weighted by current market value.
- Listings worldwide
- 1,348
- U.S. companies with a market value
- 1,217
- Market value
- $10.8T
- Share of U.S. market value
- 7.9%
- Return, 1D
- −0.0%
- Return, 5D
- +1.7%
- Return, 1M
- +2.9%
- Return, 6M
- +17.0%
- Return, YTD
- +21.7%
- Return, 1Y
- +48.7%
Health care market map
The sector’s largest U.S.-listed companies, sized by market value and coloured by their move.
Largest companies
The 100 most valuable U.S.-listed companies in health care, with revenue and net income from their latest annual report. All are listed in the United States.
| # | Company | Ticker | Market value | Price | 1D | YTD | 1Y | Revenue | Net income | Employees |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | LLY | $1.2T | 1,251.75 | −0.4% | +16.5% | +55.9% | $65.2B | $20.6B | – |
| 2 | Johnson & Johnson | JNJ | $612.9B | 254.33 | −0.5% | +22.9% | +31.6% | $94.2B | $26.8B | – |
| 3 | AbbVie | ABBV | $502.0B | 284.09 | −0.5% | +24.3% | +23.8% | $61.2B | $4.2B | – |
| 4 | Procter & Gamble | PG | $367.1B | 157.95 | −0.9% | +10.2% | +4.3% | $87.0B | $16.0B | – |
| 5 | UnitedHealth Group | UNH | $364.8B | 406.41 | +1.2% | +23.1% | +14.0% | $447.6B | $12.1B | – |
| 6 | Merck & Co. | MRK | $355.1B | 143.95 | −1.4% | +36.8% | +69.8% | $65.0B | $18.3B | – |
| 7 | Novartis | NVS | $292.1B | 150.44 | −0.1% | +9.1% | +14.5% | – | $14.0B | – |
| 8 | AstraZeneca | AZN | $261.6B | 165.15 | −0.2% | −10.2% | −2.5% | $58.7B | $10.2B | – |
| 9 | Thermo Fisher Scientific Inc. | TMO | $251.7B | 680.79 | −1.3% | +17.5% | +26.3% | $44.6B | $6.7B | – |
| 10 | Amgen | AMGN | $231.3B | 427.80 | −1.1% | +30.7% | +43.2% | $36.8B | $7.7B | – |
| 11 | Siemens | SIE.F | $229.0B | 264.35 EUR | −1.6% | +10.7% | +11.1% | – | – | – |
| 12 | Gilead Sciences | GILD | $191.7B | 154.64 | −1.0% | +26.0% | +25.9% | $29.4B | $8.5B | – |
| 13 | Abbott Laboratories | ABT | $180.8B | 103.80 | −1.0% | −17.1% | −19.2% | $44.3B | $6.5B | – |
| 14 | Novo | NVO | $173.2B | 38.54 | −0.8% | −24.2% | −29.1% | – | – | 69,505 |
| 15 | Pfizer | PFE | $168.0B | 29.48 | −0.3% | +18.4% | +20.3% | $62.6B | $7.8B | – |
| 16 | Intuitive Surgical | ISRG | $153.0B | 433.03 | +1.5% | −23.5% | −2.9% | $10.1B | $2.9B | – |
| 17 | Vertex Pharmaceuticals | VRTX | $127.2B | 501.74 | +0.4% | +10.7% | +20.4% | $12.0B | $4.0B | – |
| 18 | Bristol-Myers Squibb | BMY | $120.9B | 59.19 | −0.9% | +9.7% | +35.6% | $48.2B | $7.1B | – |
| 19 | Medtronic plc | MDT | $119.0B | 93.03 | −1.8% | −3.1% | −2.9% | $36.4B | $4.8B | – |
| 20 | Stryker Corporation | SYK | $114.5B | 298.54 | +1.3% | −15.1% | −20.3% | $25.1B | $3.2B | – |
| 21 | Corning Inc. | GLW | $114.1B | 132.43 | +0.3% | +51.2% | +56.7% | $15.6B | $1.6B | – |
| 22 | Marriott International | MAR | $101.8B | 390.25 | +0.6% | +25.8% | +49.6% | $26.2B | $2.6B | – |
| 23 | HCA Healthcare | HCA | $101.2B | 456.23 | −0.6% | −2.3% | +7.1% | $75.6B | $6.8B | – |
| 24 | GSK | GSK | $100.3B | 49.60 | +0.2% | +1.1% | +12.9% | – | – | – |
| 25 | Sanofi | SNY | $98.4B | 39.67 | −2.3% | −18.1% | −21.6% | – | – | – |
| 26 | Elevance Health, Inc. | ELV | $93.0B | 428.91 | +0.1% | +22.4% | +23.0% | $199.1B | $5.7B | – |
| 27 | Moderna | MRNA | $90.5B | 226.67 | +4.0% | +668.6% | +771.5% | $1.9B | −$2.8B | – |
| 28 | Regeneron Pharmaceuticals | REGN | $82.8B | 784.87 | −0.7% | +1.7% | +35.8% | $14.3B | $4.5B | – |
| 29 | Hilton Worldwide | HLT | $77.6B | 344.86 | −0.1% | +20.1% | +32.5% | $12.0B | $1.5B | – |
| 30 | WuXi AppTec | 2359.HK | $75.8B | 196.20 HKD | −2.2% | +98.2% | +85.1% | – | – | – |
| 31 | Honeywell | HON | $66.8B | 210.67 | −0.3% | +3.0% | +5.0% | $37.4B | $4.7B | – |
| 32 | Boston Scientific | BSX | $65.2B | 44.98 | +1.3% | −52.8% | −54.7% | $20.1B | $2.9B | – |
| 33 | Cencora | COR | $64.8B | 339.52 | −0.4% | +0.5% | +4.6% | $321.3B | $1.6B | – |
| 34 | Takeda Pharmaceutical Company | TAK | $63.7B | 19.63 | −0.2% | +25.9% | +39.8% | – | – | – |
| 35 | Aflac | AFL | $59.7B | 119.05 | −0.8% | +8.0% | +10.5% | $17.2B | $3.6B | – |
| 36 | Cardinal Health | CAH | $58.3B | 250.53 | −1.4% | +21.9% | +60.2% | $254.2B | $1.7B | – |
| 37 | Natera | NTRA | $58.0B | 402.54 | +2.3% | +75.7% | +121.5% | $2.3B | −$208.2M | – |
| 38 | Argenx SE | ARGX | $55.7B | 826.28 | +0.9% | −1.7% | −2.1% | – | $1.3B | – |
| 39 | Siemens Healthineers | SMMNY | $52.3B | 22.91 | −0.9% | −12.7% | −18.1% | – | – | – |
| 40 | Becton Dickinson | BDX | $52.2B | 191.58 | −0.1% | +25.6% | +28.9% | $21.8B | $1.7B | – |
| 41 | Edwards Lifesciences | EW | $50.4B | 87.49 | +1.0% | +2.6% | +17.2% | $6.1B | $1.1B | – |
| 42 | Bayer | BAYN.F | $49.2B | 43.37 EUR | −1.7% | +17.3% | +60.7% | – | – | – |
| 43 | Teva Pharmaceutical Industries Ltd. | TEVA | $48.2B | 41.39 | −0.3% | +32.6% | +114.3% | $17.3B | $1.4B | – |
| 44 | Medline Inc. | MDLN | $47.4B | 35.38 | −1.6% | −15.8% | – | $28.4B | $1.2B | – |
| 45 | Jiangsu Hengrui Medicine | 600276.SS | $47.1B | 46.63 CNY | +0.1% | −21.7% | −30.2% | – | – | – |
| 46 | Coherent, Inc. | COHR | $45.6B | 232.82 | −0.0% | +26.1% | +100.1% | $7.1B | $805.0M | – |
| 47 | Sun Pharmaceutical | SUNPHARMA.NS | $44.1B | 1,758.80 INR | −0.3% | +2.3% | +6.0% | – | – | – |
| 48 | IQVIA Holdings, Inc. | IQV | $44.1B | 264.27 | −1.0% | +17.2% | +29.2% | $16.3B | $1.4B | 93,000 |
| 49 | IDEXX Laboratories, Inc. | IDXX | $44.1B | 559.16 | −0.2% | −17.4% | −12.0% | $4.3B | $1.1B | – |
| 50 | BeOne Medicines Ltd. | ONC | $43.9B | 371.86 | +0.8% | +22.4% | +17.5% | $5.3B | $286.9M | 12,000 |
| 51 | Sandoz | SDZ.SW | $41.1B | 76.58 CHF | −0.8% | +32.4% | +58.2% | – | – | – |
| 52 | Illumina | ILMN | $39.6B | 262.52 | −0.0% | +100.2% | +175.0% | $4.3B | $850.0M | – |
| 53 | Revolution Medicines (United States) | RVMD | $39.0B | 182.09 | +2.3% | +128.6% | +236.6% | $0 | −$1.1B | – |
| 54 | Royalty Pharma plc | RPRX | $36.1B | 60.48 | −0.8% | +56.5% | +63.4% | $2.4B | $770.9M | – |
| 55 | ResMed | RMD | $34.6B | 239.64 | +0.3% | −0.5% | −10.6% | $5.7B | $1.5B | – |
| 56 | Biogen | BIIB | $34.5B | 233.58 | +0.4% | +32.7% | +63.3% | $9.9B | $1.3B | – |
| 57 | Centene Corporation | CNC | $33.5B | 67.77 | −2.0% | +64.7% | +92.2% | $174.6B | −$6.7B | – |
| 58 | Zoetis | ZTS | $32.9B | 79.70 | +0.4% | −36.6% | −44.7% | $9.5B | $2.7B | – |
| 59 | Alcon | ALC | $32.7B | 66.00 | −0.3% | −16.2% | −12.1% | $10.4B | $980.0M | – |
| 60 | Mettler Toledo | MTD | $32.6B | 1,627.94 | +0.3% | +16.8% | +20.6% | $4.0B | $869.2M | – |
| 61 | Dexcom | DXCM | $32.5B | 86.09 | +0.1% | +29.7% | +29.3% | $4.7B | $836.3M | – |
| 62 | GE HealthCare | GEHC | $31.6B | 69.53 | −0.1% | −15.2% | −6.1% | $20.6B | $2.1B | – |
| 63 | Alnylam Pharmaceuticals | ALNY | $31.5B | 235.58 | +1.6% | −40.8% | −51.1% | $3.7B | $313.7M | – |
| 64 | Fresenius SE & Co. KGaA | FSNUY | $28.8B | 12.72 | 0.0% | −11.2% | −9.1% | – | – | – |
| 65 | Astellas Pharma | 4503.T | $28.2B | 2,418.50 JPY | +2.6% | +15.6% | +50.0% | – | – | – |
| 66 | West Pharmaceutical Services (United States) | WST | $27.1B | 384.40 | +0.1% | +39.7% | +42.0% | $3.1B | $493.7M | – |
| 67 | Zai Lab Limited | ZLAB | $26.9B | 24.01 | +3.5% | +36.1% | −15.1% | $457.2M | −$175.5M | – |
| 68 | Hansoh Pharmaceutical Group | 3692.HK | $26.6B | 31.74 HKD | +1.1% | −12.0% | −11.2% | – | – | – |
| 69 | Quest Diagnostics | DGX | $26.0B | 235.13 | +0.1% | +35.5% | +24.1% | $11.0B | $992.0M | – |
| 70 | WuXi Biologics | 2269.HK | $25.9B | 48.20 HKD | −0.9% | +53.3% | +31.5% | – | – | – |
| 71 | LabCorp | LH | $25.8B | 318.40 | +0.1% | +26.9% | +11.3% | $14.0B | $876.5M | 70,000 |
| 72 | Divi's Laboratories | DIVISLAB.NS | $25.7B | 9,087.00 INR | – | +42.1% | +37.2% | – | – | – |
| 73 | Fujifilm Corporation | 4901.T | $25.6B | 3,432.00 JPY | +0.9% | +2.6% | −1.3% | – | – | – |
| 74 | Roivant | ROIV | $25.3B | 35.01 | +4.4% | +61.3% | +102.8% | $8.3M | −$299.8M | – |
| 75 | Genmab A/s | GMAB | $24.2B | 38.59 | +4.3% | +25.3% | +16.3% | $3.7B | $963.0M | – |
| 76 | Sartorius Stedim Biotech | DIM.PA | $23.5B | 211.80 EUR | −1.5% | +0.9% | +4.5% | – | – | – |
| 77 | UNITED THERAPEUTICS Corp | UTHR | $23.4B | 544.42 | +2.1% | +11.7% | +25.6% | $3.2B | $1.3B | – |
| 78 | Principal Financial Group | PFG | $23.2B | 107.33 | −1.4% | +21.7% | +36.5% | $15.6B | $1.2B | – |
| 79 | BioNTech | BNTX | $23.0B | 89.17 | +1.7% | −6.3% | −15.2% | – | – | – |
| 80 | Incyte | INCY | $22.7B | 113.77 | +0.6% | +15.2% | +29.9% | $5.1B | $1.3B | – |
| 81 | Terumo | 4543.T | $22.4B | 2,337.00 JPY | +1.5% | +3.0% | −6.2% | – | – | – |
| 82 | Steris | STE | $21.7B | 222.18 | −0.2% | −12.4% | −7.5% | $5.9B | $782.3M | 3,700 |
| 83 | Tenet Healthcare | THC | $21.5B | 267.33 | +0.0% | +34.5% | +33.7% | $21.3B | $2.4B | – |
| 84 | Guardant Health | GH | $21.3B | 159.04 | +0.3% | +55.7% | +143.0% | $982.0M | −$416.3M | – |
| 85 | Viatris | VTRS | $20.9B | 18.23 | −2.3% | +46.4% | +79.2% | $14.3B | −$3.5B | 30,000 |
| 86 | INSMED Inc | INSM | $20.9B | 95.67 | −0.6% | −45.0% | −42.3% | $606.4M | −$1.3B | – |
| 87 | Dr. Sulaiman Al Habib Medical Services Group | 4013.SR | $20.1B | 219.20 SAR | −1.3% | −14.7% | −21.4% | – | – | – |
| 88 | Straumann | SAUHY | $18.7B | 11.18 | −0.9% | −4.0% | +2.3% | – | – | – |
| 89 | Torrent Pharmaceuticals | TORNTPHARM.NS | $18.2B | 4,558.90 INR | −0.6% | +18.4% | +29.0% | – | – | – |
| 90 | Zimmer Biomet Holdings | ZBH | $18.1B | 95.01 | +0.0% | +5.7% | −6.8% | $8.2B | $705.1M | – |
| 91 | Medpace | MEDP | $17.4B | 622.70 | +0.7% | +10.9% | +17.9% | $2.5B | $451.1M | – |
| 92 | IHH Healthcare | 5225.KL | $17.2B | 8.00 MYR | +0.2% | −8.6% | −0.5% | – | – | – |
| 93 | Revvity Inc. | RVTY | $17.0B | 152.28 | −0.2% | +57.4% | +63.0% | $2.9B | $241.2M | – |
| 94 | Hyatt Hotels Corporation | H | $16.9B | 171.99 | +1.7% | +7.3% | +18.3% | $7.1B | −$52.0M | – |
| 95 | Shionogi | 4507.T | $16.2B | 2,934.00 JPY | +1.4% | +3.3% | +21.4% | – | – | – |
| 96 | Coloplast | COLO-B.CO | $15.9B | 466.90 DKK | −1.1% | −14.6% | −20.3% | – | – | – |
| 97 | Ascendis Pharma A/S | ASND | $15.8B | 230.59 | +2.4% | +8.1% | +9.5% | – | – | – |
| 98 | Exelixis | EXEL | $15.5B | 62.59 | +0.6% | +42.8% | +59.5% | $2.3B | $782.6M | – |
| 99 | UL Solutions Inc. | ULS | $14.7B | 73.27 | −0.1% | −7.1% | −2.8% | $3.1B | $325.0M | – |
| 100 | Solventum | SOLV | $14.5B | 85.44 | −0.4% | +7.8% | +18.4% | $8.3B | $1.6B | – |
Prices: daily closing prices and 15-minute quotes collected by On the record from public market data; market values are the share count in each company’s latest SEC filing times the last price. Sectors come from each company’s industry in SEC EDGAR and Wikidata. Prices are for reference only. Revenue, net income and employees: each company’s latest annual report (10-K) filed with the SEC, from SEC EDGAR XBRL data. Employee counts are reported by few companies.
Biggest moves on the latest session
Companies worth $1 billion or more, on the U.S. session of Oct 19, 2026.
Up the most
- Silence Therapeutics plc+125.5%SLN · $2.8B
- Disc Medicine, Inc.+37.9%IRON · $3.0B
- Arcutis Biotherapeutics, Inc.+12.8%ARQT · $4.1B
- Dasa S.A.+12.0%DASA3.SA · $1.3B
- Parabilis Medicines, Inc.+11.6%PBLS · $3.1B
- Veradermics, Inc+11.3%MANE · $5.1B
- Maze Therapeutics, Inc.+10.3%MAZE · $1.7B
- Agios Pharmaceuticals+9.7%AGIO · $2.1B
- Taysha Gene Therapies, Inc.+9.2%TSHA · $1.3B
- Viridian Therapeutics, Inc.\DE+8.9%VRDN · $2.3B
Down the most
- Mesoblast−9.3%MESO · $1.7B
- Ocular Therapeutix, Inc−8.9%OCUL · $1.4B
- ImmunityBio, Inc.−6.9%IBRX · $9.1B
- North China Pharmaceutical Group Corp−4.7%600812.SS · $1.4B
- Ipca Laboratories−4.2%IPCALAB.NS · $5.1B
- Ambu−4.2%AMBU-B.CO · $3.0B
- City Therapeutics, INC.−4.1%CTY · $1.0B
- Novavax−3.9%NVAX · $1.8B
- Scinai Immunotherapeutics Ltd.−3.6%SCNI · $10.1B
- Pennant Group, Inc.−3.4%PNTG · $1.4B
Industries
The industries the 1,348 listings describe themselves as in, from SEC and Wikidata records. 91 industries; the 60 largest by count are shown.
| Industry | Listings | U.S. market value | YTD | 1Y | Largest U.S. company |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 479 | $498.5B | +21.3% | +38.7% | BeOne Medicines Ltd. |
| Pharmaceutical industry | 145 | $4.0T | +15.7% | +34.3% | Eli Lilly and Company |
| Biological Products, (No Diagnostic Substances) | 134 | $166.2B | +67.8% | +110.1% | Revolution Medicines (United States) |
| Surgical & Medical Instruments & Apparatus | 131 | $207.0B | +17.3% | +33.2% | Medline Inc. |
| Biotechnology | 52 | $319.6B | +35.7% | +55.0% | Argenx SE |
| Medicinal Chemicals & Botanical Products | 34 | $8.8B | −35.4% | −28.2% | Regencell Bioscience |
| Electromedical & Electrotherapeutic Apparatus | 31 | $17.7B | +17.8% | +29.3% | LivaNova PLC |
| Services-Medical Laboratories | 25 | $92.6B | +59.4% | +1775.9% | Natera |
| Orthopedic, Prosthetic & Surgical Appliances & Supplies | 24 | $168.1B | −22.0% | −1.7% | Intuitive Surgical |
| Health care | 23 | $392.5B | +12.1% | +20.7% | HCA Healthcare |
| Biotechnology industry | 20 | $299.9B | +31.3% | +45.6% | Thermo Fisher Scientific Inc. |
| In Vitro & In Vivo Diagnostic Substances | 17 | $12.8B | +43.4% | +65.1% | Lantheus Holdings, Inc. |
| Health care industry | 16 | $59.8B | +21.1% | +17.5% | Steris |
| Laboratory Analytical Instruments | 15 | $101.6B | +26.7% | +60.3% | Coherent, Inc. |
| Services-Health Services | 15 | $14.8B | +24.0% | +41.2% | LifeStance Health Group, Inc. |
| Hospitality industry | 14 | $141.6B | +12.4% | +21.8% | Hilton Worldwide |
| Services-Misc Health & Allied Services, NEC | 13 | $9.3B | +70.8% | +59.4% | Sotera Health Co |
| Services-Commercial Physical & Biological Research | 12 | $19.8B | +19.4% | +22.7% | Medpace |
| Services-Offices & Clinics of Doctors of Medicine | 10 | $1.9B | +34.5% | +22.9% | Starling Oncology, Inc. |
| Medical technology | 7 | $130.0B | −13.5% | −15.0% | Stryker Corporation |
| Services-Home Health Care Services | 7 | $29.2B | +34.0% | +50.0% | BrightSpring Health Services, Inc. |
| Biotechnology, pharmaceutical industry | 6 | $627.3B | +19.7% | +21.2% | AbbVie |
| Wholesale-Drugs, Proprietaries & Druggists' Sundries | 6 | $57.8M | −25.0% | −57.8% | Cosmos Health Inc. |
| Medical device | 5 | $85.3B | −1.6% | +5.9% | Edwards Lifesciences |
| Accident & Health Insurance | 5 | $99.7B | +14.6% | +18.3% | Aflac |
| Chemical industry, pharmaceutical industry | 4 | $346.7B | +12.1% | +20.4% | Novartis |
| Health insurance | 4 | $472.4B | +22.2% | +15.2% | UnitedHealth Group |
| Medical technology industry | 4 | $312.1B | −11.6% | −13.1% | Abbott Laboratories |
| Biomedical engineering | 4 | $34.5B | +5.6% | +12.8% | Zimmer Biomet Holdings |
| Retail-Drug Stores and Proprietary Stores | 4 | $2.5B | +32.3% | +59.6% | Guardian Pharmacy Services, Inc. |
| Dental Equipment & Supplies | 4 | $3.7B | +4.6% | +13.7% | Envista Holdings Corporation |
| Ophthalmic Goods | 4 | $2.7B | −22.8% | −25.0% | National Vision Holdings, Inc. |
| Services-Testing Laboratories | 3 | $14.7B | −7.1% | −2.8% | UL Solutions Inc. |
| Biopharmaceutical | 3 | – | – | – | – |
| Biomedicine | 2 | $2.9B | +4.2% | −7.2% | Hutchison China Meditech |
| Services-General Medical & Surgical Hospitals, NEC | 2 | $12.4B | −9.8% | −12.0% | Universal Health Services |
| Health information technology | 2 | $76.7M | −38.2% | −41.8% | CareCloud |
| Hospitality industry, retail | 2 | – | – | – | – |
| Pharmaceutical company | 2 | $1.5B | −13.1% | −4.5% | Natco Pharma |
| Medicine | 2 | $34.6B | −0.6% | −10.7% | ResMed |
| Health care industry, pharmaceutical industry | 2 | $49.8B | +13.0% | +28.1% | Fresenius SE & Co. KGaA |
| Services-Hospitals | 2 | $2.2B | +28.6% | +67.2% | Pediatrix Medical Group |
| Laboratory Apparatus & Furniture | 2 | $98.5M | −12.0% | −23.0% | Kewaunee Scientific Corp /de/ |
| Biotechnology industry, pharmaceutical industry | 2 | $90.5B | +668.6% | +771.5% | Moderna |
| Pharmacy | 2 | $9.2B | −3.6% | +7.9% | RaiaDrogasil |
| Hospitality industry, hotel industry | 1 | $1.7B | −17.6% | −13.1% | Shangri-La Hotels and Resorts |
| Hospitality industry, retail, tourism industry | 1 | – | – | – | – |
| Laboratory diagnostics, tertiary sector of the economy | 1 | $910.3M | −0.7% | +8.3% | BML |
| Document Solutions, medical imaging, photo industry, photographic process, printing company | 1 | $25.6B | +2.6% | −1.3% | Fujifilm Corporation |
| Biotechnology, petrochemical industry | 1 | – | – | – | – |
| Health care, pharmaceutical industry | 1 | $252.3M | −44.2% | −40.0% | Pharmaniaga |
| Hospital & Medical Service Plans | 1 | $1.7B | −58.3% | −51.9% | Alignment Healthcare, Inc. |
| Cellular therapy and transplantation, autoimmune disease, biotechnology, multiple sclerosis, oncology | 1 | $92.7M | −48.9% | −37.6% | Atara Biotherapeutics, Inc. |
| Medical equipment | 1 | $12.9B | +30.9% | +8.3% | Baxter International |
| Chemical industry, pharmaceutical industry, phytopharmaceuticals, plastic | 1 | $49.2B | +17.3% | +60.7% | Bayer |
| Chemical industry, cosmetics industry, manufacture of glues, manufacture of perfumes and toilet preparations, manufacture of pharmaceutical preparations | 1 | – | – | – | – |
| Electrophysiology, interventional cardiology, interventional radiology, medical device, neuromodulation | 1 | $65.2B | −52.8% | −54.7% | Boston Scientific |
| Research and development in biotechnology | 1 | $94.7M | −81.4% | −77.4% | Cellectis |
| Health club | 1 | – | – | – | – |
| Cannabis industry | 1 | $2.0B | +1.3% | −11.0% | Curaleaf Holdings, Inc. |
Most traded outside the United States
Listings on non-U.S. exchanges, ranked by average daily trading value over 20 sessions (in dollars). We don’t hold market values for these, and prices are in the local currency.
| Company | Region | Price | 1D | YTD | 1Y | Avg daily $ volume |
|---|---|---|---|---|---|---|
| Jiangsu Hengrui Medicine600276.SS | Asia-Pacific | 46.63 CNY | +0.1% | −21.7% | −30.2% | $408.6M |
| WuXi Biologics2269.HK | Asia-Pacific | 48.20 HKD | −0.9% | +53.3% | +31.5% | $222.8M |
| WuXi AppTec2359.HK | Asia-Pacific | 196.20 HKD | −2.2% | +98.2% | +85.1% | $129.8M |
| Andon Health002432.SZ | Asia-Pacific | 53.18 CNY | −0.5% | +32.8% | +30.4% | $106.9M |
| SandozSDZ.SW | Europe | 76.58 CHF | −0.8% | +32.4% | +58.2% | $96.6M |
| North China Pharmaceutical Group Corp600812.SS | Asia-Pacific | 6.26 CNY | −4.7% | +13.2% | +4.9% | $93.9M |
| Astellas Pharma4503.T | Asia-Pacific | 2,418.50 JPY | +2.6% | +15.6% | +50.0% | $87.6M |
| Terumo4543.T | Asia-Pacific | 2,337.00 JPY | +1.5% | +3.0% | −6.2% | $84.9M |
| Fujifilm Corporation4901.T | Asia-Pacific | 3,432.00 JPY | +0.9% | +2.6% | −1.3% | $84.4M |
| CSPC Pharmaceutical Group1093.HK | Asia-Pacific | 8.88 HKD | +0.2% | +5.2% | −4.2% | $82.8M |
| Beta Pharma Inc.300558.SZ | Asia-Pacific | 42.02 CNY | +0.1% | −10.0% | −28.6% | $78.5M |
| Yunnan Baiyao Group000538.SZ | Asia-Pacific | 53.08 CNY | +0.3% | −6.5% | −8.0% | $65.9M |
| Shionogi4507.T | Asia-Pacific | 2,934.00 JPY | +1.4% | +3.3% | +21.4% | $60.7M |
| HD Medicine000963.SZ | Asia-Pacific | 26.25 CNY | −0.2% | −33.5% | −35.8% | $56.7M |
| RaiaDrogasilRADL3.SA | Other Americas | 21.45 BRL | +4.3% | −8.5% | +11.7% | $52.9M |
| Divi's LaboratoriesDIVISLAB.NS | Asia-Pacific | 9,087.00 INR | – | +42.1% | +37.2% | $50.1M |
| Asahi Kasei3407.T | Asia-Pacific | 1,602.50 JPY | +2.3% | +15.4% | +35.0% | $45.4M |
| Cochlear LimitedCOH.AX | Asia-Pacific | 132.55 AUD | – | −49.1% | −53.6% | $41.5M |
| Eisai4523.T | Asia-Pacific | 4,920.00 JPY | +1.1% | +5.6% | +8.7% | $38.2M |
| Sumitomo Pharma4506.T | Asia-Pacific | 1,840.50 JPY | −0.1% | −20.6% | +2.9% | $37.9M |
| Hansoh Pharmaceutical Group3692.HK | Asia-Pacific | 31.74 HKD | +1.1% | −12.0% | −11.2% | $35.2M |
| AccorAC.PA | Europe | 45.48 EUR | −3.0% | −5.7% | +9.4% | $32.6M |
| Sun PharmaceuticalSUNPHARMA.NS | Asia-Pacific | 1,758.80 INR | −0.3% | +2.3% | +6.0% | $31.0M |
| Jointown Pharmaceutical Group600998.SS | Asia-Pacific | 4.93 CNY | −1.8% | −3.7% | 0.0% | $28.4M |
| LBX Pharmacy603883.SS | Asia-Pacific | 14.17 CNY | −1.9% | −4.3% | −14.3% | $27.2M |
Upcoming earnings
Results dates for health care companies listed in the United States, largest first on each day.
- Oct 21Thermo Fisher Scientific Inc. TMOQuarter ending Sep/2026; last year $5.79 a share; before the open; worth $251.7B
- Oct 21Abbott Laboratories ABTQuarter ending Sep/2026; last year $1.30 a share; before the open; worth $180.8B
- Oct 21Elevance Health, Inc. ELVQuarter ending Sep/2026; last year $6.03 a share; before the open; worth $93.0B
- Oct 21
- Oct 21Molina Healthcare MOHQuarter ending Sep/2026; last year $1.84 a share; after the close; worth $10.9B
- Oct 21Wyndham Hotels & Resorts WHQuarter ending Sep/2026; last year $1.46 a share; after the close; worth $5.7B
- Oct 21Integra Lifesciences Holdings Corp IARTQuarter ending Sep/2026; last year $0.54 a share; before the open; worth $1.0B
- Oct 21
- Oct 22
- Oct 22
- Oct 22
- Oct 22Quest Diagnostics DGXQuarter ending Sep/2026; last year $2.60 a share; before the open; worth $26.0B
- Oct 22
- Oct 22
- Oct 22
- Oct 23
- Oct 26Principal Financial Group PFGQuarter ending Sep/2026; last year $2.10 a share; after the close; worth $23.2B
- Oct 26
- Oct 26
- Oct 27
- Oct 27
- Oct 27
- Oct 27
- Oct 27IQVIA Holdings, Inc. IQVQuarter ending Sep/2026; last year $2.73 a share; before the open; worth $44.1B
- Oct 27Centene Corporation CNCQuarter ending Sep/2026; last year $0.50 a share; before the open; worth $33.5B
- Oct 27
- Oct 27Universal Health Services UHSQuarter ending Sep/2026; last year $5.69 a share; after the close; worth $10.8B
- Oct 27
- Oct 27
- Oct 27Chemed Corporation CHEQuarter ending Sep/2026; last year $4.94 a share; after the close; worth $6.6B
- Oct 27Kiniksa Pharmaceuticals International, plc KNSAQuarter ending Sep/2026; last year $0.23 a share; worth $6.3B
- Oct 27
- Oct 27
- Oct 27
- Oct 27
- Oct 27Beta Bionics, Inc. BBNXQuarter ending Sep/2026; last year ($0.33) a share; after the close; worth $762.6M
- Oct 27Orthopediatrics Corp KIDSQuarter ending Sep/2026; last year ($0.24) a share; after the close; worth $576.0M
- Oct 27SS Innovations International, Inc. SSIIQuarter ending Sep/2026; last year ($0.02) a share; worth $482.9M
- Oct 27Nautilus Biotechnology, Inc. NAUTQuarter ending Sep/2026; last year ($0.11) a share; before the open; worth $327.0M
- Oct 27
- Oct 27
- Oct 28
- Oct 28Boston Scientific BSXQuarter ending Sep/2026; last year $0.75 a share; before the open; worth $65.2B
- Oct 28
- Oct 28
- Oct 28
- Oct 28
- Oct 28
- Oct 28Align Technology ALGNQuarter ending Sep/2026; last year $2.07 a share; after the close; worth $10.6B
- Oct 28
- Oct 28MGM Resorts International MGMQuarter ending Sep/2026; last year $0.24 a share; after the close; worth $7.1B
- Oct 28
- Oct 28
- Oct 28
- Oct 28
- Oct 28
- Oct 28CONMED Corporation CNMDQuarter ending Sep/2026; last year $1.08 a share; after the close; worth $1.4B
- Oct 28
- Oct 28Mimedx Group, INC. MDXGQuarter ending Sep/2026; last year $0.15 a share; after the close; worth $635.5M
- Oct 28Community Health Systems CYHQuarter ending Sep/2026; last year $1.27 a share; after the close; worth $394.1M
Dates from public earnings calendars (Nasdaq), as collected by On the record. Companies change dates; check their investor pages.
Recent 8-K filings
8-Ks report material events: results, deals, leadership changes, big contracts. Latest in our records: Oct 15, 2026.
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 15
- Oct 14
- Oct 14
- Oct 14
- Oct 14
- Oct 14
- Oct 14
- Oct 14
- Oct 14
- Oct 14
Filings from SEC EDGAR.